244 related articles for article (PubMed ID: 18207348)
1. CMY-20, a novel AmpC-type beta-lactamase from South African clinical Escherichia coli isolates.
Mocktar C; Govinden U; Sturm AW; Essack SY
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):405-8. PubMed ID: 18207348
[TBL] [Abstract][Full Text] [Related]
2. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
[TBL] [Abstract][Full Text] [Related]
4. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP
Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic beta-lactamase during a 5-year period in a French teaching Hospital.
Corvec S; Crémet L; Leprince C; Dauvergne S; Reynaud A; Lepelletier D; Caroff N
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):277-81. PubMed ID: 20462724
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.
Mammeri H; Eb F; Berkani A; Nordmann P
J Antimicrob Chemother; 2008 Mar; 61(3):498-503. PubMed ID: 18250231
[TBL] [Abstract][Full Text] [Related]
7. [A new member of CMY type cephalosporinase prevailing in Escherichia coli].
Guan XZ; Liu YN; Luo YP; She DY; Zhou G; Chen LA; Xu YP
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1872-5. PubMed ID: 15631796
[TBL] [Abstract][Full Text] [Related]
8. Dissemination of Escherichia coli producing AmpC-type beta-lactamase (CMY-11) in Korea.
Kim JY; Song JS; Bak SH; Cho YE; Kim DW; Jeong SH; Park YM; Lee KJ; Lee SH
Int J Antimicrob Agents; 2004 Oct; 24(4):320-6. PubMed ID: 15380255
[TBL] [Abstract][Full Text] [Related]
9. Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals.
Bogaerts P; Rodriguez-Villalobos H; Laurent C; Deplano A; Struelens MJ; Glupczynski Y
J Antimicrob Chemother; 2009 May; 63(5):1073-5. PubMed ID: 19240070
[No Abstract] [Full Text] [Related]
10. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin.
García-Fernández A; Chiaretto G; Bertini A; Villa L; Fortini D; Ricci A; Carattoli A
J Antimicrob Chemother; 2008 Jun; 61(6):1229-33. PubMed ID: 18367460
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of class A and AmpC β-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan.
Hussain M; Hasan F; Shah AA; Hameed A; Jung M; Rayamajhi N; Cha SB; Yoo HS
Jpn J Infect Dis; 2011; 64(3):249-52. PubMed ID: 21617313
[TBL] [Abstract][Full Text] [Related]
12. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
Mammeri H; Nazic H; Naas T; Poirel L; Léotard S; Nordmann P
Antimicrob Agents Chemother; 2004 Oct; 48(10):4050-3. PubMed ID: 15388478
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
14. AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131.
Oteo J; Cercenado E; Cuevas O; Bautista V; Delgado-Iribarren A; Orden B; Pérez-Vázquez M; García-Cobos S; Campos J
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):270-6. PubMed ID: 20462723
[TBL] [Abstract][Full Text] [Related]
15. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
Rodríguez I; Barownick W; Helmuth R; Mendoza MC; Rodicio MR; Schroeter A; Guerra B
J Antimicrob Chemother; 2009 Aug; 64(2):301-9. PubMed ID: 19474065
[TBL] [Abstract][Full Text] [Related]
16. Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates.
Manageiro V; Ferreira E; Pinto M; Fonseca F; Ferreira M; Bonnet R; Caniça M
Ann Clin Microbiol Antimicrob; 2015 Mar; 14():12. PubMed ID: 25885413
[TBL] [Abstract][Full Text] [Related]
17. [CMY-2-type plasmid-mediated AmpC ß-lactamases emerging in Tucumán, Argentina].
Jure MA; Presti C; Cudmani NM; Grellet LM; López C; Musa EH; Aulet OC; Nieto C; Saavedra L; de Castillo MC
Rev Argent Microbiol; 2011; 43(1):24-7. PubMed ID: 21491062
[TBL] [Abstract][Full Text] [Related]
18. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.
Wu SW; Dornbusch K; Kronvall G; Norgren M
Antimicrob Agents Chemother; 1999 Jun; 43(6):1350-7. PubMed ID: 10348751
[TBL] [Abstract][Full Text] [Related]
19. Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.
Literacka E; Empel J; Baraniak A; Sadowy E; Hryniewicz W; Gniadkowski M
Antimicrob Agents Chemother; 2004 Nov; 48(11):4136-43. PubMed ID: 15504832
[TBL] [Abstract][Full Text] [Related]
20. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
